A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study. [electronic resource]
Producer: 20060406Description: 1366-71 p. digitalISSN:- 1592-8721
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Disease Progression
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cell Mobilization
- Humans
- Ifosfamide -- administration & dosage
- Injections, Spinal
- Lenograstim
- Leucovorin -- administration & dosage
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Mesna -- administration & dosage
- Methotrexate -- administration & dosage
- Middle Aged
- Peripheral Blood Stem Cell Transplantation
- Pilot Projects
- Prognosis
- Recombinant Proteins -- therapeutic use
- Salvage Therapy
- Sepsis -- mortality
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.